CTCX fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
Carmell Corp. is a regenerative medicine biotech company, which focuses on leveraging its core platform technology plasma based bioactive material to stimulate tissue repair or growth after severe injury, disease or aging. Its products include Bone Healing Accelerant and Tissue Healing Accelerant. The company was founded on November 5, 2008 and is headquartered in Pittsburgh, PA.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
CTCX does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future
Financial health
Financial position and solvency of the company